|
Market Closed -
Other stock markets
|
After hours 22:36:37 | |||
| 108.00 USD | 0.00% |
|
107.31 | -0.64% |
| 09:49pm | US FDA approves Gilead's twice-yearly injection for HIV prevention | RE |
| 08:39pm | Gilead Sciences' Twice-Yearly HIV-Prevention Drug Gets FDA Approval | DJ |
Main competitors
| Fundamentals (Composite) | Global Valuation (Composite) | Consensus (Composite) | Financial estimates revisions (Composite) | Visibility (Composite) | Investor (Composite) | ESG MSCI | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
AAA | 134B | ||||||||
A | 710B | ||||||||
A | 367B | ||||||||
AAA | 335B | ||||||||
A | 328B | ||||||||
A | 258B | ||||||||
AA | 230B | ||||||||
AA | 223B | ||||||||
A | 197B | ||||||||
A | 156B | ||||||||
A | 136B | ||||||||
BBB | 119B | ||||||||
AA | 114B | ||||||||
A | 96.12B | ||||||||
AA | 83.75B | ||||||||
AA | 80.92B | ||||||||
A | 47.87B | ||||||||
A | 46.77B | ||||||||
A | 46.73B | ||||||||
| Average | AA | 195.16B | |||||||
| Weighted average by Cap. | AA |
- Stock Market
- Equities
- GILD Stock
- Sector Gilead Sciences, Inc.
- Sector ratings
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition